TI-495

N/A

Report date: 2023/08/02 17:09:51

Base Information

Drug NameTI-495

Drug Alias NameTI-495

ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy

Mechanisms of ActionT lymphocyte replacements

TargetsUpdating

Therapy Area/IndicationsRejection of organ transplantation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTeraImmune Inc

China Registration ClassN/A

Develop Information

Active CompaniesTeraImmune Inc

Inactive CompaniesN/A

Active IndicationsRejection of organ transplantation

Inactive IndicationsN/A

Other Information

ATC CodeN/A